Subscribe Now To entree exclusive content, subscribe to STAT+
A biotech institution that hoped to usage compartment biology to code neurological disorders is shutting down.
Faze Medicines was built by VC Third Rock Ventures and launched successful 2020 with $81 cardinal from Third Rock, Casdin Capital, and task funds tally by cause giants Novartis, Eli Lilly, and AbbVie.
Unlock this nonfiction by subscribing to STAT+ and bask your archetypal 30 days free!
About the Author Reprints
Allison DeAngelis
Biotech Startups and Venture Capital Reporter
Allison is simply a biotech newsman astatine STAT, covering biopharma startups and task capital.
Trending
In Arizona’s contention for governor, Kari Lake fans Republican…
In Arizona’s contention for governor, Kari Lake fans Republican fury implicit Fauci, fentanyl and gender-affirming care
Pfizer, BioNTech study caller Covid booster is much protective…
Pfizer, BioNTech study caller Covid booster is much protective against caller Omicron variants than archetypal vaccine
Providers of methadone attraction accidental a large summation in…
Providers of methadone attraction accidental a large summation successful entree could backfire
Recommended
The Supreme Court volition reappraisal a contentious Amgen patent…
The Supreme Court volition reappraisal a contentious Amgen patent case, but not 1 involving Bristol. Why?
Talkspace names a caller CEO arsenic its banal price…
Talkspace names a caller CEO arsenic its banal terms continues to struggle
Pharmalittle: Biogen mulls caller options successful its CEO hunt;…
Pharmalittle: Biogen mulls caller options successful its CEO hunt; NIH starts contacting universities astir overdue trial…
Recommended Stories
Following your gut: How scientists are getting person to linking the microbiome and chronic diseases
advertisement
Biotech Adam Feuerstein, Matthew Herper and Damian Garde
J&J’s Mammen retired of the moving for Biogen CEO post
Following your gut: How scientists are getting person to linking the microbiome and chronic diseases